Between two of largest drugmakers in the world, here are one Fool's thoughts on which stock is the better buy right now.
Big pharma stocks like Eli Lilly (NYSE:LLY) and GlaxoSmithKline (NYSE:GSK) can
be great long-term additions to your portfolio, especially in turbulent
economic environments. After all, pharma companies tend to fare well even in
the worst of times due to the nature of their underlying business: People
generally don't stop buying medicine simply because the economy isn't doing
well.
With this in mind, let's consider whether Lilly or Glaxo is the better buy right now...
Source: The Motley Fool